LM8-33537-20986

2 vaccinations 1 coded response 2 check-ins 0 free-text entries 0 call cases

Sex: Female
Age at first dose: 05-11
ZIP prefix: 930 / CA
Registered: 2022-06-27

Relationship: Child or adolescent in my care
Guardian: LS5-21565-20552
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-12-20
Dose 1 — Pfizer-BioNTech
Co-administered: Flu:MMR:Tetanus
2022-01-17
Dose 2 — Pfizer-BioNTech
Co-administered: Chickenpox:Polio
2022-06-27
Registered in v-safe
2022-07-18
Health check-in — 6 months, dose 2, dependent
Feeling: Good

Adult check-in
2023-01-17
Survey response — 12 months, dose 2, dependent
MedDRA: Malaise — Feeling: Fair · Be unable to work or attend school

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-12-20	Pfizer-BioNTech	Flu:MMR:Tetanus
2	2022-01-17	Pfizer-BioNTech	Chickenpox:Polio

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Malaise	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release